Aptevo Therapeutics Inc (NASDAQ:APVO) has a beta value of 5.89 and has seen 56.83 million shares traded in the last trading session. The company, currently valued at $2.05M, closed the last trade at $0.64 per share which meant it lost -$0.22 on the day or -26.24% during that session. The APVO stock price is -7878.12% off its 52-week high price of $51.06 and -29.69% below the 52-week low of $0.83. If we look at the company’s 10-day average daily trading volume, we find that it stood at 6.18 million shares traded. The 3-month trading volume is 1.88 million shares.
Aptevo Therapeutics Inc (NASDAQ:APVO) trade information
Sporting -26.24% in the red in last session, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the APVO stock price touched $0.64 or saw a rise of 52.59%. Year-to-date, Aptevo Therapeutics Inc shares have moved -85.25%, while the 5-day performance has seen it change -37.06%. Over the past 30 days, the shares of Aptevo Therapeutics Inc (NASDAQ:APVO) have changed -74.26%. Short interest in the company has seen 0.39 million shares shorted with days to cover at 4.92.
Aptevo Therapeutics Inc (APVO) estimates and forecasts
The company’s shares have lost -88.93% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 0.00%.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 80.96% over the past 5 years. Earnings growth for 2025 is a modest 81.87% while over the next 5 years, the company’s earnings are expected to increase by 51.40%.
APVO Dividends
Aptevo Therapeutics Inc is expected to release its next earnings report on 2025-Feb-13 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Aptevo Therapeutics Inc (NASDAQ:APVO)’s Major holders
Insiders own 6.21% of the company shares, while shares held by institutions stand at 14.78% with a share float percentage of 15.76%. Investors are also buoyed by the number of investors in a company, with Aptevo Therapeutics Inc having a total of 18.0 institutions that hold shares in the company.
Also the top two Mutual Funds that are holding company’s shares are Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund . As of Feb 28, 2025 , the former fund manager holds about 0.04% shares in the company for having 1.16 shares of worth $736.0 while later fund manager owns 668.0 shares of worth $424.0 as of Feb 28, 2025 , which makes it owner of about 0.02% of company’s outstanding stock.
